Sestamibi SPECT/CT与仅SPECT在原发性甲状旁腺功能亢进术前定位中的比较:单中心8年分析
该单中心8年队列研究比较了SPECT/CT与仅SPECT在散发性原发性甲状旁腺功能亢进术前定位的准确性。在1,388例患者中,单腺体病变的SPECT/CT准确性优于SPECT(83% vs 77%,P=.02),多腺体病变的预测准确性也更高(36% vs 22%,P=.04)。阳性SPECT/CT结果对单腺体和多腺体病变均提供更可靠的手术指导。
要点
- SPECT/CT对单腺体病变的定位准确性显著优于仅SPECT(83% vs 77%,P=.02)。
- 多腺体病变中SPECT/CT预测准确性更高(36% vs 22%,P=.04)。
- 阳性SPECT/CT结果对单腺体和多腺体病变均提供更可靠的手术指导。
核心结论
- 在散发性原发性甲状旁腺功能亢进行甲状旁腺切除术的患者中,阳性SPECT/CT结果对单腺体和多腺体病变均比仅SPECT提供更可靠的手术指导。
研究设计与样本
- 单中心前瞻性数据库查询,纳入2006-2014年初次探查且随访≥6个月以明确解剖的散发性原发性甲状旁腺功能亢进患者。
- 2010年前患者接受仅SPECT(n=633),2010年后接受SPECT/CT(n=755),共1,388例。
主要发现
- 在1,186例单腺体病变患者中,SPECT/CT的阳性预测值略高(90% vs 85%),准确性优于SPECT(83% vs 77%,P=.02)。
- 在202例多腺体病变患者中,20%影像学阴性,SPECT/CT与SPECT阴性率无差异(17% vs 23%,P=.3),但SPECT/CT预测多腺体病变的准确性更高(36% vs 22%,P=.04)。
- 两队列间单腺体病变率(P=.8)、双侧探查率(P=.4)和阴性影像率(145例,P=.33)均相等。
临床怎么用
- 对于散发性原发性甲状旁腺功能亢进患者,术前定位可优先考虑SPECT/CT,因其对单腺体和多腺体病变的阳性结果更可靠。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Primary hyperparathyroidism is caused by single gland disease in 85% of cases and by multiglandular disease in 15%. Our aim was to discover if the addition of computed tomography acquisition/fusion on a hybrid scanner to traditional dual-phase single-photon emission tomography improves localization accuracy. METHODS: A prospective database was queried for the perioperative data of patients with sporadic primary hyperparathyroidism who had initial exploration from 2006-2014 with ≥6 month follow-up to define anatomy. Prior to 2010, patients had single-photon emission tomography (n = 633); after 2010, they had single-photon emission tomography/computed tomography (n= 755). RESULTS: In 1,388 patients, the rates of single gland disease (P=.8), bilateral exploration (P=.4), and negative imaging (145 patients, P=.33) were equal between imaging cohorts. In 1,186 patients with single gland disease, the positive predictive value of single-photon emission tomography/computed tomography was somewhat greater (90% vs 85%) and the accuracy of single-photon emission tomography/computed tomography was superior (83% vs 77%, P=.02). In the 202 patients with multiglandular disease, 20% had negative imaging results with no difference by type (single-photon emission tomography/computed tomography 17%, single-photon emission tomography 23%, P=.3), but single-photon emission tomography/computed tomography was more accurate (36%) than single-photon emission tomography (22%, P=.04) in predicting multiglandular disease. CONCLUSION: In a large cohort study of patients with sporadic primary hyperparathyroidism undergoing parathyroidectomy, positive single-photon emission tomography/computed tomography results provided more reliable operative guidance than single-photon emission tomography for both single gland disease and multiglandular disease.
引用
- McCoy KL, Ghodadra AG, Hiremath TG, et al. Sestamibi SPECT/CT versus SPECT only for preoperative localization in primary hyperparathyroidism: a single institution 8-year analysis. Surgery. 2018. PMID: 29310821. doi:10.1016/j.surg.2017.10.064
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。